Can amiodarone (antiarrhythmic medication) increase the risk of myocardial infarction in patients with thyroid storm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amiodarone and Myocardial Infarction Risk in Thyroid Storm

Amiodarone should be avoided in patients with thyroid storm due to its potential to exacerbate thyrotoxicosis and increase cardiovascular complications, including the risk of myocardial infarction. 1, 2

Relationship Between Amiodarone and Thyroid Dysfunction

  • Amiodarone can cause thyroid dysfunction due to its high iodine content and structural similarity to thyroid hormones 3
  • Two types of amiodarone-induced thyrotoxicosis (AIT) can occur:
    • Type 1: Increased synthesis of thyroid hormone in abnormal thyroid glands
    • Type 2: Destructive thyroiditis causing excess release of thyroid hormones 4, 3
  • Amiodarone-induced thyrotoxicosis occurs in 7-15% of patients taking the medication 4

Cardiovascular Risks in Thyroid Storm

  • Thyroid storm is a life-threatening condition with mortality rates approaching 20% 5
  • Cardiovascular manifestations of thyroid storm include:
    • Tachyarrhythmias
    • Hypotension
    • Heart failure exacerbation
    • Increased myocardial oxygen demand 5, 6
  • These effects can precipitate myocardial ischemia in susceptible individuals 1

Amiodarone Use in Thyroid Disease

  • Guidelines clearly state that amiodarone should be discontinued in patients who develop iatrogenic hyperthyroidism 1
  • The American College of Cardiology/American Heart Association guidelines emphasize that "the risks and benefits of treating patients with AF with a known history of thyroid disease with amiodarone should be carefully weighed before initiation of therapy" 1
  • Patients with thyroid disease receiving amiodarone require close monitoring of thyroid function 2

Management of Arrhythmias in Thyroid Storm

  • Beta-blockers are the first-line treatment for rate control in patients with thyroid storm and arrhythmias 1
  • Non-dihydropyridine calcium channel antagonists (diltiazem, verapamil) are recommended alternatives when beta-blockers are contraindicated 1
  • The European Society of Cardiology specifically recommends beta-blockers for controlling ventricular rate in thyroid storm 1

Mechanism of Potential Myocardial Infarction Risk

  • Thyroid storm increases myocardial oxygen demand through:
    • Increased heart rate
    • Increased contractility
    • Systemic vasodilation 1, 6
  • Amiodarone may worsen thyrotoxicosis in patients with thyroid storm, potentially leading to:
    • Further increases in cardiac workload
    • Coronary vasospasm
    • Tachyarrhythmias resistant to treatment 5, 6
  • Cases of amiodarone-induced thyroid storm causing sustained ventricular tachycardia have been reported 5

Clinical Implications and Recommendations

  • For patients with thyroid storm requiring antiarrhythmic therapy:
    • Beta-blockers should be first-line treatment 1
    • Calcium channel blockers are appropriate alternatives 1
    • Amiodarone should be discontinued if it was previously prescribed 1
  • If a patient with thyroid storm has life-threatening ventricular arrhythmias:
    • Direct current cardioversion is recommended for hemodynamically unstable patients 1
    • Alternative antiarrhythmic agents should be considered 1
  • Regular thyroid function monitoring is essential for all patients on amiodarone 2, 3

Pitfalls and Caveats

  • Amiodarone has an extremely long half-life (averaging 58 days), so discontinuation may not provide immediate benefit in acute thyroid storm 2, 3
  • Mixed types of amiodarone-induced thyrotoxicosis are common and can be challenging to diagnose and treat 3
  • Patients with cardiac disease receiving amiodarone should be monitored for signs of thyroid dysfunction, which may manifest as worsening of underlying cardiac disease 2, 3
  • Thyroid storm associated with amiodarone use can develop even after years of stable therapy 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Safe Use of Amiodarone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Amiodarone-induced thyroid dysfunction.

Journal of intensive care medicine, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.